Big Pharma's big push into Africa's cancer market
Africa is a burgeoning market for cancer drugs. But as pharmaceutical companies like Roche are learning in Kenya, the challenges are immense.
Source: swissinfo.ch
📰 Series Access News
Series Access News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Series Access. Real-time updates on events, politics, business and more.
Paying to survive – the deadly toll of breast cancer in Kenya
In Kenya, the high price of drugs like trastuzumab, which Roche sells as Herceptin, is one reason why breast cancer is still seen as a death sentence.
Source: swissinfo.ch
Novartis's big bet on sickle cell disease struggles to reach Kenya
Pharma giants are pouring money into new therapies for sickle cell disease but in Kenya, patients struggle to access a decades-old drug.
Source: swissinfo.ch
Novartis's big bet on sickle cell disease struggles to reach Kenya
Pharma giants are pouring money into new therapies for sickle cell disease but in Kenya, patients struggle to access a decades-old drug.
Source: swissinfo.ch
The end of affordable medicine
Pharma companies are close to a cure for cancer, but will the hefty price tags make treatments unaffordable for most of the world?
Source: swissinfo.ch
Why life-saving drugs aren't saving lives in Kenya
There have been huge advances in the treatment of cancer and other genetic diseases over the last decade. Why arent they available everywhere?
Source: swissinfo.ch